Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive parameters for in vivo alloreactivity.

Frans H J Claas1

  • 1Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands. fhjclaas@lumc.nl

Transplant Immunology
|September 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA-DQA1*03:02-DQB1*03:03 is the Dominant Immunogenic Heterodimer for Posttransplant HLA-DQ De Novo DSA Development in a Cohort of Chinese Kidney Transplant Patients.

Transplantation·2025
Same author

Belgian Consensus Guidelines Within Eurotransplant on Imlifidase-enabled Deceased Donor Kidney Transplantation in Highly Sensitized Patients.

Transplantation·2025
Same author

Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.

Transplant international : official journal of the European Society for Organ Transplantation·2025
Same author

Proficiency testing within Eurotransplant.

Frontiers in genetics·2024
Same author

Introduction of the donor centre virtual crossmatch in Eurotransplant.

HLA·2024
Same author

Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party study.

Blood advances·2024

Predicting alloimmune responses after transplantation remains challenging. The HLA Matchmaker algorithm shows promise in identifying HLA mismatches unlikely to cause antibody formation, aiding donor selection.

Area of Science:

  • Immunology
  • Transplantation Science
  • Genetics

Background:

  • Alloimmune responses can occur despite optimal HLA matching and negative crossmatch in transplantation and transfusions.
  • Graft rejection, graft vs. host disease, and platelet refractoriness are severe consequences of alloimmune reactions.
  • Predictive parameters for alloimmune responses often lack individual patient impact.

Purpose of the Study:

  • To identify reliable methods for predicting alloimmune responses before transplantation or transfusion.
  • To evaluate existing and potential predictive algorithms for donor-recipient compatibility.
  • To improve outcomes by selecting donor/recipient combinations that minimize destructive alloimmune reactions.

Main Methods:

  • Analysis of retrospective graft survival data.

Related Experiment Videos

  • In vitro testing of T and B cell alloreactivity.
  • Application and evaluation of the HLA Matchmaker algorithm.

    • Main Results:

    • Most predictive parameters are statistically relevant at a population level but not for individual patients.
    • The HLA Matchmaker algorithm demonstrates potential in predicting the absence of alloantibody formation.
    • Predicting T cell alloreactivity requires further development of in vitro tools or algorithm adaptation.

    Conclusions:

    • Accurate prediction of individual alloimmune responses is crucial for transplantation and transfusion success.
    • The HLA Matchmaker algorithm offers a promising molecular approach for predicting HLA-driven alloantibody formation.
    • Further research is needed to refine T cell alloreactivity prediction and understand NK cell roles in alloimmune reactions.